About Merck Specialities Private Limited
Data last updated:
Merck Specialities Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Merck Holding Gmbh. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 18 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2005PTC152680. Its GSTIN is 06AAECM2634B2ZZ (Haryana). The company holds 31 GST registrations, of which 10 are active.
The company has an authorised share capital of ₹150 Cr and a paid-up capital of ₹95.34 Cr. It is led by directors Pratima Kodathala Reddy (Managing Director) and Suneela Milind Thatte.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Godrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli East, Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,027.41 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹214.21 Cr (net margin 20.8%) and EBITDA of ₹303.12 Cr (EBITDA margin 29.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 15% over five years.
The company has about 818 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Merck. Court records list 12 cases involving the company, including 5 filed by the company and 7 filed against it; 5 cases are pending. The company has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹760.8 Cr; the latest was in January 2019. Its 9 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 5 smaller; the largest is Mylan Pharmaceuticals Private Limited with revenue of ₹1,253.34 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 14 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merckgroup.com.
Company details
Contact details
Merck Specialities Private Limited's registered office is in Mumbai, Maharashtra. Its website is merckgroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGodrej One 8th Floor Pirojshanagar Eastern Express Highway Vikhroli East, Mumbai, Maharashtra, India – 400079
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Merck Specialities Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Merck Specialities operates one associated brand: Merck. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Merck is engaged in science and technology solutions globally. | merckgroup.com |
Business activity
The main business activity of Merck Specialities is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Merck Specialities Private Limited, buy the company report.
Financials of Merck Specialities Private Limited
FY 2025 filings availableMerck Specialities Private Limited reported revenue of ₹1,027.41 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 13% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹303.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹214.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.5% | ||||
| Net Profit Margin | 20.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Merck Specialities Private Limited, buy the company report.
Board of directors of Merck Specialities Private Limited
Merck Specialities has 2 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratima Kodathala Reddy Also directs: The Indo German Chamber of Commerce | Managing Director | 16 Aug 2022 | 4 Years 2 Months | Current |
| Suneela Milind Thatte | Director | 30 Jun 2023 | 3 Years 3 Months | Current |
Peer comparison
Merck Specialities Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mylan Pharmaceuticals Private Limited | ₹1,253.34 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Aquatic Remedies Limited | ₹1,226.14 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Sanjeevani Pharma Distributors Private Limited | ₹1,076.67 Cr (FY 2025) | 47.0% | Hyderabad, Telangana, India | |||
| Mahaveer Medi-Sales Private Limited | ₹1,044.79 Cr (FY 2025) | 27.0% | Mumbai, Maharashtra, India | |||
| Merck Specialities Private Limitedthis company | ₹1,027.41 Cr (FY 2025) | ₹214.21 Cr | 20.8% | 13.0% | 818 | Mumbai, Maharashtra, India |
| Eli Lilly and Company (India ) Private Limited | ₹1,003.67 Cr (FY 2025) | 25.0% | Haryana, India | |||
| Systopic Laboratories Private Limited | ₹925.45 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Akna Medical Private Limited | ₹899.75 Cr (FY 2025) | -7.0% | Thane, Maharashtra, India | |||
| Neelkanth Drugs Private Limited | ₹897.65 Cr (FY 2023) | 38.0% | Hyderabad, Telangana, India | |||
| Bristol-Myers Squibb India Private Limited | ₹881.76 Cr (FY 2025) | 40.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Merck Specialities Private Limited, buy the company report.
Auditor
Merck Specialities Private Limited is audited by M. A. Parikh Shah & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. A. Parikh Shah & Associates | FY 2023 | 107556W |
Shareholding
The shareholding of Merck Specialities Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Merck Specialities Private Limited, buy the company report.
Deals & funding
Merck Specialities Private Limited has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹760.8 Cr; the latest was in January 2019.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Funding round | ₹678.15 Cr | Investors: Merck Holdings GmbH |
| Mar 2017 | Secondary share transfer | Undisclosed | Seller: Merck Holdings GmbH |
| Oct 2009 | Funding round | ₹31.92 Cr | Investors: Merck Holdings GmbH |
| Jan 2007 | Funding round | ₹73.3 Lakh | Investors: Merck Holdings GmbH |
To see the full deal history of Merck Specialities Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Merck Specialities Private Limited has 12 court cases on record: 5 filed by Merck Specialities, 7 filed against it. 5 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 6 | 5 |
| District courts | 3 | 1 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Writ petition | Filed against the company by M/S Transasia Bio Medicals Ltd | Disposed |
| High Court | Interim or miscellaneous application | Filed against the company by PR Commissioner of Income Tax 8 | Pending |
| High Court, GUJARAT | Special civil application | Filed by the company against State of Gujarat and 1 other | Pending |
| High Court | Interim or miscellaneous application | Filed against the company by PR Commissioner of Income Tax 8 Mumbai | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Drugs Controller General of India & Anr. | Pending |
To see the full case history of Merck Specialities Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Merck Specialities Private Limited was last rated by Icra on 11 Sep 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 11 Sep 2020 |
To see the full credit ratings and regulatory alerts of Merck Specialities Private Limited, buy the company report.
MSME payment delays
Merck Specialities Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nuvanijaya Online Services Private Limited | |||
| NGPL Paper Pack Private Limited | |||
| Positive Industries LLP | |||
| Shiv Offset (India) Private Limited | |||
| Mediaxcess |
To see the full MSME payment records of Merck Specialities Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Merck Specialities Private Limited has a workforce of 818 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Merck Specialities has 31 GST registrations: 10 active and 21 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECM2634B2ZZ | Haryana | Active | 05 Oct 2018 |
| 19AAECM2634B2ZS | West Bengal | Active | 05 Oct 2018 |
| 24AAECM2634B2Z1 | Gujarat | Active | 05 Oct 2018 |
| 29AAECM2634B3ZQ | Karnataka | Active | 05 Oct 2018 |
To see the full GST registrations and return filing status of Merck Specialities Private Limited, buy the company report.
Recent activity
Merck Specialities Private Limited has 34 board changes on record since 2005: 18 appointments and 16 cessations. The latest: Hemlata Vikram Kulkarni ceased to be Director on 30 Jun 2023.
25 earlier events are in the company report.
News
Frequently asked questions
Merck Specialities is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 18 April 2005 (21+ years old) and is registered under CIN U24100MH2005PTC152680.
Merck Specialities has 2 current directors:
- Pratima Kodathala Reddy - Managing Director
- Suneela Milind Thatte - Director
The latest financial statements of Merck Specialities on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Merck Specialities is 06AAECM2634B2ZZ, registered in Haryana. The company has 31 GST registrations in all, of which 10 are active and 21 are cancelled or inactive. Other active GSTINs include 19AAECM2634B2ZS (West Bengal), 24AAECM2634B2Z1 (Gujarat), 29AAECM2634B3ZQ (Karnataka).
The CIN (Corporate Identification Number) of Merck Specialities is U24100MH2005PTC152680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Merck Specialities has 12 court cases on record: 5 filed by the company and 7 filed against it. 5 are pending. Most are in the high courts.
Merck Specialities was incorporated on 18 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Merck Specialities has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹760.8 Cr; the latest was in January 2019.
The peers of Merck Specialities by revenue are Mylan Pharmaceuticals Private Limited, Aquatic Remedies Limited, Sanjeevani Pharma Distributors Private Limited, Mahaveer Medi-Sales Private Limited, Eli Lilly and Company (India ) Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hemlata Vikram Kulkarni ceased to be Director on 30 Jun 2023. Suneela Milind Thatte was appointed as Director on 30 Jun 2023. Anandram Narasimhan ceased to be Managing Director on 16 Aug 2022. Merck Specialities has 34 board changes on record in total.
Merck Specialities has 9 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 14 micro and small suppliers. The latest return was filed on 25 Apr 2023.
Merck Specialities can be reached through the website merckgroup.com. Its registered office is in Mumbai, Maharashtra, India.